189 related articles for article (PubMed ID: 28327480)
1. Pharmacotherapy of patients with stable bronchial asthma.
Aggarwal AN
Natl Med J India; 2016; 29(6):330-337. PubMed ID: 28327480
[TBL] [Abstract][Full Text] [Related]
2. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK
J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798
[TBL] [Abstract][Full Text] [Related]
3. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
Nelson HS
J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
[TBL] [Abstract][Full Text] [Related]
4. Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma.
Price D; Bousquet J
Respir Med; 2012 Dec; 106 Suppl 1():S4-8. PubMed ID: 23273164
[TBL] [Abstract][Full Text] [Related]
5. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
[TBL] [Abstract][Full Text] [Related]
6. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
Aalbers R; Vogelmeier C; Kuna P
Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
Tamm M; Richards DH; Beghé B; Fabbri L
Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
[TBL] [Abstract][Full Text] [Related]
9. Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.
Turner S; Richardson K; Murray C; Thomas M; Hillyer EV; Burden A; Price DB;
J Allergy Clin Immunol Pract; 2017; 5(1):99-106.e3. PubMed ID: 27421902
[TBL] [Abstract][Full Text] [Related]
10. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
11. Inhaled beta 2-agonists and corticosteroids in the treatment of children with acute asthma attack.
Volovitz B; Nussinovitch M
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):891-2. PubMed ID: 12455174
[No Abstract] [Full Text] [Related]
12. Managing a variable disease.
Kips J
Pulm Pharmacol Ther; 2002; 15(6):485-90. PubMed ID: 12493334
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists.
McKeage K
Drugs; 2015 May; 75(7):809-16. PubMed ID: 25895466
[TBL] [Abstract][Full Text] [Related]
14. Management of asthma in resource-limited settings: role of low-cost corticosteroid/β-agonist combination inhaler.
Chiang CY; Aït-Khaled N; Bissell K; Enarson DA
Int J Tuberc Lung Dis; 2015 Feb; 19(2):129-36. PubMed ID: 25574908
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid plus β
Wang G; Zhang X; Zhang HP; Wang L; Kang Y; Barnes PJ; Wang G
Respir Res; 2017 Dec; 18(1):203. PubMed ID: 29207999
[TBL] [Abstract][Full Text] [Related]
16. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
Demoly P; Louis R; Søes-Petersen U; Naya I; Carlsheimer A; Worth H; Almeida J; Sears MR
Respir Med; 2009 Nov; 103(11):1623-32. PubMed ID: 19762222
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological consequences of inhaled drug delivery to small airways in the treatment of asthma.
Bodzenta-Łukaszyk A; Kokot M
Adv Ther; 2014 Aug; 31(8):803-16. PubMed ID: 25116888
[TBL] [Abstract][Full Text] [Related]
18. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process.
Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F
Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206
[TBL] [Abstract][Full Text] [Related]
19. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
Petite SE
Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
[TBL] [Abstract][Full Text] [Related]
20. Fixed-Dose Combination Inhalers.
Cazzola M; Matera MG
Handb Exp Pharmacol; 2017; 237():117-129. PubMed ID: 27783268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
